Description

Metabolomic and transcriptomic analyses of fecal and oral samples identify altered gene transcripts and chemical compounds during IBS exacerbation. These multi-omics findings suggest coordinated gut-brain axis dysregulation.

Figure 4

Chart

Source Paper

Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation.

Journal of gastroenterology (2022)

PMID: 35908139

DOI: 10.1007/s00535-022-01888-2

Cite This Figure

![Figure 4: Metabolomic and transcriptomic analyses of fecal and oral samples identify altered gene transcripts and chemical compounds during IBS exacerbation. These multi-omics findings suggest coordinated gut-brain axis dysregulation.]()

> Source: Yukari Tanaka et al. "Omics profiles of fecal and oral microbiota change in irritable bowel syndrome p." *Journal of gastroenterology*, 2022. PMID: [35908139](https://pubmed.ncbi.nlm.nih.gov/35908139/)

<figure>
  <img src="" alt="Metabolomic and transcriptomic analyses of fecal and oral samples identify altered gene transcripts and chemical compounds during IBS exacerbation. These multi-omics findings suggest coordinated gut-brain axis dysregulation." />
  <figcaption>Figure 4. Metabolomic and transcriptomic analyses of fecal and oral samples identify altered gene transcripts and chemical compounds during IBS exacerbation. These multi-omics findings suggest coordinated gut-brain axis dysregulation.<br>  Source: Yukari Tanaka et al. "Omics profiles of fecal and oral microbiota change in irritable bowel syndrome p." <em>Journal of gastroenterology</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35908139/">35908139</a></figcaption>
</figure>

Preuves associées

L-Glutamine pour Irritable Bowel Syndrome (IBS)

Note C · 2 études